Colgate-Palmolive (CL) Scheduled to Post Earnings on Friday

Colgate-Palmolive (NYSE:CLGet Rating) is set to release its earnings data before the market opens on Friday, January 27th. Analysts expect Colgate-Palmolive to post earnings of $0.76 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Colgate-Palmolive (NYSE:CLGet Rating) last posted its quarterly earnings results on Friday, October 28th. The company reported $0.74 EPS for the quarter, meeting analysts’ consensus estimates of $0.74. The firm had revenue of $4.46 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Colgate-Palmolive had a net margin of 10.87% and a return on equity of 304.29%. The business’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.81 earnings per share. On average, analysts expect Colgate-Palmolive to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Colgate-Palmolive Stock Up 0.6 %

Shares of CL traded up $0.44 on Tuesday, hitting $75.94. 4,215,780 shares of the stock traded hands, compared to its average volume of 4,620,075. Colgate-Palmolive has a one year low of $67.84 and a one year high of $83.81. The company has a market capitalization of $63.43 billion, a PE ratio of 33.02, a P/E/G ratio of 6.61 and a beta of 0.51. The business has a 50 day simple moving average of $77.74 and a 200 day simple moving average of $76.72. The company has a debt-to-equity ratio of 7.81, a quick ratio of 0.71 and a current ratio of 1.17.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 14th. Shareholders of record on Monday, January 23rd will be issued a $0.47 dividend. This represents a $1.88 dividend on an annualized basis and a dividend yield of 2.48%. The ex-dividend date of this dividend is Friday, January 20th. Colgate-Palmolive’s payout ratio is 81.74%.

Institutional Investors Weigh In On Colgate-Palmolive

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CL. Dimensional Fund Advisors LP increased its stake in Colgate-Palmolive by 4.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock worth $185,376,000 after buying an additional 94,837 shares in the last quarter. Covestor Ltd grew its position in shares of Colgate-Palmolive by 71.9% during the first quarter. Covestor Ltd now owns 2,451 shares of the company’s stock worth $186,000 after purchasing an additional 1,025 shares in the last quarter. Mackenzie Financial Corp raised its stake in Colgate-Palmolive by 8.5% during the 1st quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock valued at $142,774,000 after purchasing an additional 146,936 shares during the period. First Western Trust Bank purchased a new position in Colgate-Palmolive in the 1st quarter worth approximately $569,000. Finally, Wsfs Capital Management LLC bought a new position in Colgate-Palmolive in the 1st quarter worth approximately $288,000. 77.63% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CL shares. UBS Group decreased their target price on Colgate-Palmolive from $90.00 to $80.00 in a research report on Thursday, October 13th. Wolfe Research initiated coverage on shares of Colgate-Palmolive in a report on Monday, November 21st. They issued a “market perform” rating on the stock. The Goldman Sachs Group dropped their price target on Colgate-Palmolive from $91.00 to $81.00 and set a “buy” rating on the stock in a research note on Monday, October 10th. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Thursday, December 15th. Finally, Wells Fargo & Company increased their target price on Colgate-Palmolive from $75.00 to $80.00 and gave the company an “equal weight” rating in a report on Tuesday, January 3rd. Eight investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $83.58.

About Colgate-Palmolive

(Get Rating)

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.

Recommended Stories

Earnings History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.